This episode currently has no reviews.
Submit ReviewRetailers making some major moves as holiday shopping kicks into high gear. So after a volatile 2024, can the group end the year in good spirits? Plus Health care, Biotech, and Pharma all in focus as investors digest President-Elect Donald Trump’s FDA chief pick. How the new chief will impact those spaces, and the weight-loss drug race.
This episode currently has no reviews.
Submit ReviewThis episode could use a review! Have anything to say about it? Share your thoughts using the button below.
Submit Review